5.12
Zapalna choroba jelit II: wrzodziejące zapalenie jelita grubego
Wrzodziejące zapalenie jelita grubego to przewlekłe zapalne zaburzenie jelita grubego, charakteryzujące się ciągłym zapaleniem błony śluzowej, które z…
Wrzodziejące zapalenie jelita grubego zazwyczaj zaczyna się jako reakcja na kombinację czynników immunologicznych, genetycznych lub środowiskowych.
Czynniki te prowadzą do uszkodzenia ochronnej warstwy śluzu, która normalnie wyścieła jelito grube.
Towarzyszy temu dysfunkcja ciasnych złączeń nabłonkowych, co skutkuje zwiększoną przepuszczalnością jelit.
W odpowiedzi na to naruszenie aktywowany jest układ odpornościowy. Różne komórki odpornościowe, w tym neutrofile, limfocyty, komórki plazmatyczne, makrofagi i eozynofile, są rekrutowane do błony śluzowej okrężnicy.
Komórki te uwalniają prozapalne cytokiny, takie jak czynnik martwicy nowotworów-alfa, interleukina-1, interleukina-6 oraz interleukina-13.
W miarę postępu procesu zapalnego neutrofile przenikają do krypt Lieberkühna — gruczołów rurkowatych w jelicie grubym, prowadząc do powstawania ropni krypt i niszczenia tkanki gruczołowej.
To uszkodzenie zmniejsza zdolność jelita grubego do wchłaniania wody i elektrolitów, co przyczynia się do biegunki. Równocześnie owrzodzenia błony śluzowej i kruchość naczyń włosowatych prowadzą do krwawienia z odbytu.
View the full transcript and gain access to JoVE Core videos
Q1: What causes the breakdown of the mucosal barrier in ulcerative colitis?
Ulcerative colitis begins when immunological, genetic, or environmental factors disrupt the protective mucus layer lining the colon. Defects in mucin production reduce the barrier's ability to shield epithelial cells from microbial antigens. Simultaneously, abnormalities in epithelial tight junctions increase intestinal permeability, allowing luminal bacteria and toxins to penetrate the mucosa and trigger immune activation.
Q2: Which immune cells are recruited during ulcerative colitis inflammation?
In response to mucosal barrier breach, neutrophils, lymphocytes, plasma cells, macrophages, and eosinophils are recruited to the colonic mucosa. These cells infiltrate the lamina propria and migrate into the crypts of Lieberkühn, forming characteristic crypt abscesses. Their accumulation and activation drive the inflammatory cascade that damages epithelial tissue and perpetuates disease progression.
Q3: What pro-inflammatory cytokines are released in ulcerative colitis?
Activated immune cells release pro-inflammatory cytokines including tumor necrosis factor-alpha, interleukin-1, interleukin-6, and interleukin-13. These cytokines amplify inflammation and further damage epithelial integrity. Their sustained release perpetuates the cycle of mucosal destruction and immune activation characteristic of ulcerative colitis pathophysiology.
Q4: How does neutrophil infiltration damage the colon's glandular tissue?
Neutrophils migrate into the crypts of Lieberkühn, tubular glands in the colon, forming crypt abscesses that destroy glandular tissue. This damage reduces the colon's ability to absorb water and electrolytes, contributing to diarrhea. The loss of epithelial cells and crypt architecture impairs normal colonic function and perpetuates fluid loss.
Q5: Why does ulcerative colitis cause rectal bleeding and diarrhea?
Mucosal ulceration combined with increased capillary fragility leads to rectal bleeding in ulcerative colitis. Concurrently, loss of epithelial cells and crypt architecture impairs water and electrolyte absorption, producing diarrhea. As inflammation persists, the mucosa becomes edematous, friable, and ulcerated, explaining the recurrent episodes of bloody diarrhea characteristic of the disease.
Q6: How does increased intestinal permeability initiate the immune response in ulcerative colitis?
Abnormalities in epithelial tight junctions increase intestinal permeability, allowing luminal bacteria and toxins to penetrate the mucosa. This breach activates innate and adaptive immune pathways within the gastrointestinal tract, triggering recruitment of immune cells to the colonic mucosa. The compromised barrier thus serves as the critical early step linking genetic and environmental factors to immune dysregulation.
Q7: What distinguishes ulcerative colitis from other inflammatory bowel conditions?
Ulcerative colitis is characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. This distinguishes it from conditions like inflammatory bowel disease iii crohn s disease, which may involve discontinuous inflammation. The pathophysiology involves coordinated breakdown of mucosal defenses and sustained immune activation specific to the colonic mucosa.